News Website

Weather report for Springfield - The Courier Mail

Weather report for Springfield The Courier Mail

Published: Sept. 14, 2026, 4 p.m.

Read Full Article

Weather report for Springfield - couriermail.com.au

Weather report for Springfield couriermail.com.au

Published: Sept. 13, 2026, 2:37 a.m.

Read Full Article

‘Voices to push for meaningful change’: Endometriosis sufferer starts campaign for people to be heard - Fenland Citizen

‘Voices to push for meaningful change’: Endometriosis sufferer starts campaign for people to be heard Fenland Citizen

Published: Sept. 12, 2026, 5 a.m.

Read Full Article

Jonesport voters overwhelmingly approve ordinances extending construction window for Kingfish Maine - newscentermaine.com

Jonesport voters overwhelmingly approve ordinances extending construction window for Kingfish Maine newscentermaine.com

Published: Aug. 8, 2026, 4:41 p.m.

Read Full Article

Trastuzumab Pamirtecan Provides Meaningful Survival Benefit in Pretreated HER2-Expressing Endometrial Cancer - OncLive

Trastuzumab Pamirtecan Provides Meaningful Survival Benefit in Pretreated HER2-Expressing Endometrial Cancer OncLive

Published: June 17, 2026, 9:31 p.m.

Read Full Article

BioNTech and DualityBio Report Clinically Meaningful Efficacy for Trastuzumab Pamirtecan in HER2-Expressing Endometrial Cancer - BioPharm International

BioNTech and DualityBio Report Clinically Meaningful Efficacy for Trastuzumab Pamirtecan in HER2-Expressing Endometrial Cancer BioPharm International

Published: April 15, 2026, 10:02 p.m.

Read Full Article

BioNTech, DualityBio tout 'clinically meaningful' efficacy for ADC in mid-stage endometrial cancer trial - BioSpace

BioNTech, DualityBio tout 'clinically meaningful' efficacy for ADC in mid-stage endometrial cancer trial BioSpace

Published: April 13, 2026, 5:57 p.m.

Read Full Article

BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer - The Manila Times

BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer The Manila Times

Published: April 11, 2026, 11:01 a.m.

Read Full Article

‘Very personal and especially meaningful’ Humber Bridge challenge - Hull Live

‘Very personal and especially meaningful’ Humber Bridge challenge Hull Live

Published: Feb. 26, 2026, 11:19 a.m.

Read Full Article

EXCLUSIVE: 'I thought of taking my own life...the level of pain I am in is no joke' - Longford Leader

EXCLUSIVE: 'I thought of taking my own life...the level of pain I am in is no joke' Longford Leader

Published: July 30, 2025, 1:28 p.m.

Read Full Article

Latest Articles

Weather report for Springfield - The Courier Mail

Weather report for Springfield - couriermail.com.au

‘Voices to push for meaningful change’: Endometriosis sufferer starts campaign for people to be heard - Fenland Citizen

Jonesport voters overwhelmingly approve ordinances extending construction window for Kingfish Maine - newscentermaine.com

Trastuzumab Pamirtecan Provides Meaningful Survival Benefit in Pretreated HER2-Expressing Endometrial Cancer - OncLive

BioNTech and DualityBio Report Clinically Meaningful Efficacy for Trastuzumab Pamirtecan in HER2-Expressing Endometrial Cancer - BioPharm International

BioNTech, DualityBio tout 'clinically meaningful' efficacy for ADC in mid-stage endometrial cancer trial - BioSpace

BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer - The Manila Times

‘Very personal and especially meaningful’ Humber Bridge challenge - Hull Live

EXCLUSIVE: 'I thought of taking my own life...the level of pain I am in is no joke' - Longford Leader

Subscribe to Our Newsletter